Archive: 22/04/2020
EU approves merger of Pfizer off-patent unit and Mylan
The European Commission on Wednesday authorised a merger of US drug giant Pfizer's off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.
Apr 22, 2020